3.31
price down icon0.60%   -0.02
after-market Handel nachbörslich: 3.36 0.05 +1.51%
loading

Kyverna Therapeutics Inc Aktie (KYTX) Neueste Nachrichten

pulisher
Aug 06, 2025

Kyverna Therapeutics, Inc. (NASDAQ:KYTX) Receives $15.60 Average Target Price from Analysts - MarketBeat

Aug 06, 2025
pulisher
Aug 05, 2025

Kyverna Therapeutics (KYTX) Expected to Announce Earnings on Monday - MarketBeat

Aug 05, 2025
pulisher
Aug 03, 2025

What are analysts’ price targets for Kyverna Therapeutics Inc. in the next 12 monthsInvest confidently with data-driven strategies - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What is the risk reward ratio of investing in Kyverna Therapeutics Inc. stockInvest confidently with expert support - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does Kyverna Therapeutics Inc. generate profit in a changing economyUnlock real-time stock alerts for quick profits - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are the latest earnings results for Kyverna Therapeutics Inc.Expert guidance for superior capital growth - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What analysts say about Kyverna Therapeutics Inc. stockCapital growth strategies that work - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is Kyverna Therapeutics Inc. a growth stock or a value stockAchieve superior capital gains with smart trades - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What institutional investors are buying Kyverna Therapeutics Inc. stockGet expert advice on portfolio optimization - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are Kyverna Therapeutics Inc. company’s key revenue driversOutstanding growth strategies - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

Does Kyverna Therapeutics Inc. stock perform well during market downturnsBuild wealth faster with consistent growth stocks - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

What are the technical indicators suggesting about Kyverna Therapeutics Inc.Build a portfolio for long-term financial success - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Is it the right time to buy Kyverna Therapeutics Inc. stockCapitalize on fast-growing investment opportunities - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

How volatile is Kyverna Therapeutics Inc. stock compared to the marketDynamic profit expansion - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

What catalysts could drive Kyverna Therapeutics Inc. stock higher in 2025High-profit capital plays - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Should I hold or sell Kyverna Therapeutics Inc. stock in 2025Maximize gains with professional stock picks - jammulinksnews.com

Aug 02, 2025
pulisher
Aug 01, 2025

How strong is Kyverna Therapeutics Inc. company’s balance sheetStock Strategy Recommendation From AI Tools - Jammu Links News

Aug 01, 2025
pulisher
Aug 01, 2025

Is Kyverna Therapeutics Inc. stock overvalued or undervaluedPost Market Guidance For Smart Trading - jammulinksnews.com

Aug 01, 2025
pulisher
Jul 31, 2025

Exit strategy if you’re trapped in Kyverna Therapeutics Inc.Short Term Setup With Predictive Chart Confirmed - metal.it

Jul 31, 2025
pulisher
Jul 30, 2025

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionKYTX - ACCESS Newswire

Jul 30, 2025
pulisher
Jul 29, 2025

Analysts Apply Wyckoff Model to Kyverna Therapeutics Inc. StockPattern Detection for Entry Confirmation Enabled - beatles.ru

Jul 29, 2025
pulisher
Jul 29, 2025

Trendlines Suggest Kyverna Therapeutics Inc. May Bottom Out SoonWeekly Return Pick Forecast Reports Show Trend - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Rising Star: Covington's Alicia Zhang - Law360

Jul 29, 2025
pulisher
Jul 29, 2025

Kyverna Appoints New CFO to Guide Next Growth Phase - Insider Monkey

Jul 29, 2025
pulisher
Jul 29, 2025

Kyverna Therapeutics to Host Virtual KOL Event on Neuroimmunology CAR T Franchise - AInvest

Jul 29, 2025
pulisher
Jul 29, 2025

Leading Neurologists Reveal Game-Changing CAR T Treatment for Rare Autoimmune Disorders - Stock Titan

Jul 29, 2025
pulisher
Jul 29, 2025

Published on: 2025-07-29 14:03:16 - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

What does KYTX's flat EPS in 2024 indicate for investors? - AInvest

Jul 29, 2025
pulisher
Jul 29, 2025

KYTXKyverna Therapeutics Latest Stock News & Market Updates - Stock Titan

Jul 29, 2025
pulisher
Jul 29, 2025

11 Best New Penny Stocks to Buy Right Now - Insider Monkey

Jul 29, 2025
pulisher
Jul 29, 2025

What institutions are buying Kyverna Therapeutics Inc. stock nowDaily Smart Money Movement Monitor Activated - metal.it

Jul 29, 2025
pulisher
Jul 28, 2025

Why did Kyverna's operating expenses surge in Q4 2024? - AInvest

Jul 28, 2025
pulisher
Jul 28, 2025

How many analysts rate Kyverna Therapeutics Inc. as a “Buy”Breakout Stocks Strategy With Low Risk - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Why is Kyverna Therapeutics Inc. stock attracting strong analyst attentionBest Dividend Tips From AI Tools - Jammu Links News

Jul 28, 2025
pulisher
Jul 28, 2025

Published on: 2025-07-28 19:09:23 - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

What is the dividend policy of Kyverna Therapeutics Inc. stockAchieve breakthrough gains with smart trades - Jammu Links News

Jul 28, 2025
pulisher
Jul 27, 2025

Will Kyverna Therapeutics Inc. Stock Benefit from AI and Green Energy TrendsHigh Return Investment Tips - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

Published on: 2025-07-27 18:04:27 - Jammu Links News

Jul 27, 2025
pulisher
Jul 27, 2025

How Kyverna Therapeutics Inc. stock performs during market volatilityFree Access to Investment Community - Newser

Jul 27, 2025
$78.20
price up icon 0.71%
$37.01
price down icon 0.30%
$109.30
price down icon 1.76%
$28.07
price down icon 1.58%
$111.35
price up icon 0.04%
biotechnology ONC
$298.29
price down icon 0.08%
Kapitalisierung:     |  Volumen (24h):